Drug policy of Indian pharmaceutical companies: Legal issues and challenges

With an estimated capital of over billion $ 6.5 the pharmaceutical industry of India is growing annually with the rate of 10 per cent. Evocation of patent rights on product patent has made the generic products costly. Its not wonder that pharmaceutical industry in India has come out of or one can say pruning of negative list of import. Drugs especially the life saving medicine has become costly, but what is needed is not the bulk imports but investment in this industry and notably changes that has taken place in this industry has been the growing investment on research and development. This article is all about the saga of Indian Pharmaceutical industries: its growth and development in its turbulent time not the world's as patent right has hit it most.